CIBBR Announces New
Grants
Funding supports development of new treatments for
human diseases
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The UNH Center for Integrated Biomedical and Bioengineering Research (CIBBR) recently
announced funding for research studying important human diseases that currently lack
adequate therapeutic interventions. Sherine Elsawa, associate professor of molecular, cellular
and biomedical sciences and Vicki Jeffers, assistant professor of molecular, cellular and
biomedical sciences, will each be receiving $250,000 over two years to conduct research that
has a high potential for future major National Institutes of Health (NIH) grants.
Sherine Elsawa: Preventing chronic inflammation

SHERINE ELSAWA
Sherine Elsawa’s research will focus on understanding the signaling molecules that regulate

the body’s inflammatory response, with the goal of identifying new targets to treat chronic
inflammation. Chronic inflammation is a byproduct of the body’s natural immune response and

has been linked to diseases like cancer and Rheumatoid arthritis. Results from this research
may serve as a foundation for new therapeutic approaches for these and other inflammatorymediated diseases.

“A little bit of inflammation is a good thing because it means the immune system is doing what
it’s supposed to do,” says Elsawa. “However, if the checkpoints that regulate the on/off switch
for inflammation are not tightly regulated, it can lead to chronic inflammation.”
For Elsawa, the research is also personal.
“I lost someone close to me to cancer while I was a graduate student and have focused my
career on the disease ever since,” she says. “My goal is to use my immunology and cancer
biology skills to fight the disease. I am interested in facilitating the development of novel
therapies for cancer patients based on a fundamental understanding of the molecular
mechanisms that regulate inflammation.”
Vicki Jeffers: Curing Toxoplasma gondii

VICKI JEFFERS
Vicki Jeffers’ research is focused on understanding how the Toxoplasma gondii parasite, which
infects approximately 65 million Americans and is a serious concern for pregnant women and
immunocompromised people, regulates its gene expression. The work is instrumental to
developing a cure for the parasite before it causes serious health complications in its human
host.
In most infected people the parasite is in a dormant state, but can become active if the host
becomes immunocompromised, leading to serious organ damage and death if untreated.
Currently there are no treatments that are effective when the parasite is dormant.
“The few treatments we do have available are only effective once the parasite has activated into
the disease-causing state,” she says. “Vulnerable patients who may be at risk of active infection
will often take these treatments as a preventative measure against serious disease. These
treatments may also lead to serious toxic side effects or allergic reactions, emphasizing the
need for safer, more effective therapies.”

“While I was studying microbiology as an undergrad, I became fascinated by the different ways
parasites have evolved to transmit and cause disease in humans,” says Jeffers. “Despite
advances in healthcare and biomedical research, many of the major public health challenges
faced around the world today are still due to parasitic disease. Working as a parasitologist
satisfies both my scientific curiosity, but importantly my desire to make a positive impact on
people’s lives.”
The UNH Center for Biomedical and Bioengineering Research is committed to the idea that
valuable, paradigm-shifting research is often conducted in the space between research
disciplines and across academic units. The center, which is funded by a ﬁve-year, $10 million
Center of Biomedical Research Excellence (COBRE) grant from the NIH, aims to accelerate the
translation of basic biomedical and bioengineering research into actual innovative tools and
treatments that improve human health.
To that end, the center is working to increase the number of NIH-funded research project grants
awarded to UNH faculty; spurring the hiring and advancement of biomedical and bioengineering
researchers at the university; and acquiring state-of-the-art instrumentation.
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